Cytosorbents Corp

-0.03 (-1.64%)
Earnings Announcements

CytoSorbents Reports Q2 2022 Results

Published: 08/02/2022 21:20 GMT
Cytosorbents Corp (CTSO) - Cytosorbents Reports Second Quarter 2022 Financial and Operational Results.
Cytosorbents Corp - Total Q2 2022 Revenue, Including Product Sales and Grant Income, Was $8.5 Million Versus $12.0 Million.
Cytosorbents Corp - Covid-19 Related Sales During Quarter Were Negligible Reflecting Low Severity of Current Covid-19 Illness.
Cytosorbents Corp - Decrease in Average Euro to U.S. Dollar Exchange Rate Lowered Q2 2022 Product Sales by About $840,000.
Cytosorbents Corp - Qtrly Net Loss per Common Share $0.25.
Revenue is expected to be $8.97 Million
Adjusted EPS is expected to be -$0.17

Next Quarter Revenue Guidance is expected to be $9.69 Million
Next Quarter EPS Guidance is expected to be -$0.14

More details on our Analysts Page.